Study uncovers why lupus patients have weaker response to COVID-19 vaccines
Coronavirus
Emory Health Sciences Jan 16 2025 A recent study by Emory University researchers provides new insights into why the mRNA vaccines developed to fight COVID-19 in 2021 are less effective in patients with autoimmune diseases. By providing insights into the cellular processes behind that lessened protection, the new study published in Nature Immunology, highlights that lupus patients may require tailored vaccination strategies to enhance protection against COVID-19. The findings could also offer
din zilele anterioare